Donick Cary, Reggie Watts, Jim James
As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.
As global momentum builds around psychedelic reforms, the United Nations’ Common Position on Drug Policy offers a critical framework for shaping a humane, rights-based approach to this issue on the international stage. This panel will explore how the UN’s focus on public health, human rights, and sustainable development can support decriminalization efforts, while aligning with the goals of the 2030 Agenda for Sustainable Development.
Jorge Valderrábano
Oregon and Colorado have pioneered and iterated on the first state-regulated psychedelics markets. But there are many additional ways beyond the Oregon and Colorado models to establish a market.
Leonard Gilroy, Barine Majewska, Courtney Barnes, Jared Moffat, Allison Hoots
As interest in group psychedelic-assisted therapy grows, researchers are exploring diverse protocols, populations, and psychedelic medicines to enhance therapeutic outcomes and accessibility. This panel brings together experts conducting groundbreaking studies on group-based psychedelic therapy, offering insights into how different approaches can foster healing, connection, and transformation.
Chris Stauffer, Jae Sevelius, Anthony Back
The official Opening Plenary of Psychedelic Science 2025. This 90-minute session brings the full community together to mark the start of the conference. No other programming is scheduled during this time—we invite everyone to be part of this collective moment.
Rick Williams, Ismail Lourido Ali, Betty Aldworth, Rick Doblin, Vicky Dulai
fter a week of deep learning, connection, and exploration, this final session brings us back together to reflect on where we’ve been and where we’re going.
Ismail Lourido Ali, Betty Aldworth
Within the last decade, we have witnessed a remarkable shift in cultural perceptions and narratives with respect to psychedelics. Once vilified and prohibited, psychedelics are now being hailed as catalysts for a new revolution in mental health care – even as they remain largely prohibited on the federal level.
Dennis McKenna
Paul's talk is a deep dive into psilocybin mushrooms, their past, present and future uses.
Paul Stamets
In this Keynote we will take a close look at some of the remarkable results of the large Lykos MDMA Study for PTSD which showed that MDMA opens traumatized people up to experience themselves with a deep sense of compassion and kindness.
Bessel van der Kolk
In this keynote, Dr. Anthony Estreet makes the case social workers are essential to the future of equitable psychedelic care.
Tyler Norris, Anthony Estreet
© 1986 – 2025 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mailing: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.